期刊
KIDNEY RESEARCH AND CLINICAL PRACTICE
卷 32, 期 2, 页码 52-61出版社
ELSEVIER INC
DOI: 10.1016/j.krcp.2013.04.002
关键词
Immunology; Kidney transplant; Monitoring; Recipient
Transplant biopsy has always been the gold standard for assessing the immune response to a kidney allograft (Chandraker A: Diagnostic techniques in the work-up of renal allograft dysfunction an update. Curr Opin Nephrol Hypertens 8:723-728, 1999). A biopsy is not without risk and is unable to predict rejection and is only diagnostic once rejection has already occurred. However, in the past two decades, we have seen an expansion in assays that can potentially put an end to the drug level era, which until now has been one of the few tools available to clinicians for monitoring the immune response. A better understanding of the mechanisms of rejection and tolerance, and technological advances has led to the development of new noninvasive methods to monitor the immune response. In this article, we discuss these new methods and their potential uses in renal transplant recipients. (C) 2013. The Korean Society of Nephrology. Published by Elsevier.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据